Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Avrobio Inc (AVRO US)
Watchlist
2
Analysis
Health Care
•
United States
Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
10 May 2024 04:30
Quarterly Report (Form 10-Q | Period ending 2024-03-31)
Attachment
Exchange Announcement •
04 May 2024 04:37
424B3 | Prospectus
Attachment
Exchange Announcement •
30 Apr 2024 04:55
S-4/A | Registration of securities issued in business combination transactions (Amendment)
Attachment
Exchange Announcement •
15 Apr 2024 19:37
S-4/A | Registration of securities issued in business combination transactions (Amendment)
Attachment
Exchange Announcement •
04 Apr 2024 20:17
425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x